Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P04637 (
p53
)
77,613
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
PCAF histone acetylase is found in a complex with more than 20 associated polypeptides. Here we report cloning and characterization of the 400 kDa PCAF-associated factor referred to as PAF400. PAF400 is almost identical to TRRAP, which binds to c-Myc and E2F, and has significant sequence similarities to the ATM superfamily including FRAP, ATM,
ATR
, and the catalytic subunit of DNA-PK. Remarkably, PAF400 and FRAP share sequence similarity in broad regions that cover 80% of the entire PAF400 sequence. However, unlike the other members of the ATM superfamily, PAF400 is not a protein kinase as judged from the lack of kinase motif and autophosphorylation activity. We discuss the possibility that PAF400 may play a role in signaling of DNA damage to
p53
by stimulation of
p53
acetylation.
...
PMID:The 400 kDa subunit of the PCAF histone acetylase complex belongs to the ATM superfamily. 988 74
Phosphorylation at Ser-15 may be a critical event in the up-regulation and functional activation of
p53
during cellular stress. In this report we provide evidence that the ATM-Rad3-related protein
ATR
regulates phosphorylation of Ser-15 in DNA-damaged cells. Overexpression of catalytically inactive
ATR
(ATRki) in human fibroblasts inhibited Ser-15 phosphorylation in response to gamma-irradiation and UV light. In gamma-irradiated cells, ATRki expression selectively interfered with late-phase Ser-15 phosphorylation, whereas ATRki blocked UV-induced Ser-15 phosphorylation in a time-independent manner.
ATR
phosphorylated
p53
at Ser-15 and Ser-37 in vitro, suggesting that
p53
is a target for phosphorylation by
ATR
in DNA-damaged cells.
...
PMID:A role for ATR in the DNA damage-induced phosphorylation of p53. 992 39
Cells which lack DNA-activated protein kinase (DNA-PK) are very susceptible to ionizing radiation and display an inability to repair double strand DNA breaks. DNA-PK is a member of a protein kinase family that includes
ATR
and ATM which have strong homology in their carboxy-terminal kinase domain with PL-3 kinase. ATM has been proposed to act upstream of
p53
in cellular response to ionizing radiation. DNA-PK may similarly interact with
p53
in cellular growth control and in mediation of the response to ionizing radiation.
...
PMID:Cellular response to DNA damage. Link between p53 and DNA-PK. 1019 61
Levels of the tumour suppressor
protein p53
are increased in response to a variety of DNA damaging agents. DNA damage-induced phosphorylation of
p53
occurs at serine-15 in vivo. Phosphorylation of
p53
at serine-15 leads to a stabilization of the polypeptide by inhibiting its interaction with Mdm2, a protein that targets
p53
for ubiquitin-dependent degradation. However, the mechanisms by which DNA damage is signalled to
p53
remain unclear. Here, we report the identification of a novel DNA-activated protein kinase that phosphorylates
p53
on serine-15. Fractionation of HeLa nuclear extracts and biochemical analyses indicate that this kinase is distinct from the DNA-dependent protein kinase (DNA-PK) and corresponds to the human cell cycle checkpoint protein
ATR
. Immunoprecipitation studies of recombinant
ATR
reveal that catalytic activity of this polypeptide is required for DNA-stimulated phosphorylation of
p53
on serine-15. These data suggest that
ATR
may function upstream of
p53
in a signal transduction cascade initiated upon DNA damage and provide a biochemical assay system for
ATR
activity.
...
PMID:The ataxia-telangiectasia related protein ATR mediates DNA-dependent phosphorylation of p53. 1043 22
ATW8 was a unique opportunity to review the complex and growing field of ataxia-telangiectasia (A-T) research and to cross-fertilize ideas for new experimental designs. A-T biology now encompasses human and mouse neurology, neurobiology, immunology, radiobiology, cell signalling, cell cycle checkpoints, gametogenesis, and oncogenesis, as well as radiotherapy, cancer epidemiology, premature aging, cytogenetics, and DNA repair mechanisms. By an as yet undetermined mechanism, the ATM protein appears to sense double strand breaks (DSB) during meiosis or mitosis, or breaks consequent to the damage of free radicals which are generated during the metabolism of food. As a protein kinase, ATM then directly phosphorylates
p53
and interacts with many other molecules involved in homologous and nonhomologous DSB repair, as well as in cell signalling. Some of these molecule targets include: c-abl,
ATR
, chk-1, chk-2, RPA, BRCA1, BRCA2, NFkappaB/IkappaB alpha, beta-adaptin, and perhaps ATM itself. Thus, ATM is a "hierarchical kinase," initiating many pathways simultaneously. Parallel sessions or longer meetings will clearly be necessary for future A-T workshops.
...
PMID:Eighth International Workshop on Ataxia-Telangiectasia (ATW8). 1044 4
The activation of the cysteine proteases with aspartate specificity, termed caspases, is of fundamental importance for the execution of programmed cell death. These proteases are highly specific in their action and activate or inhibit a variety of key protein molecules in the cell. Here, we study the effect of apoptosis on the integrity of two proteins that have critical roles in DNA damage signalling, cell cycle checkpoint controls, and genome maintenance-the product of the gene defective in ataxia telangiectasia, ATM, and the related protein
ATR
. We find that ATM but not
ATR
is specifically cleaved in cells induced to undergo apoptosis by a variety of stimuli. We establish that ATM cleavage in vivo is dependent on caspases, reveal that ATM is an efficient substrate for caspase 3 but not caspase 6 in vitro, and show that the in vitro caspase 3 cleavage pattern mirrors that in cells undergoing apoptosis. Strikingly, apoptotic cleavage of ATM in vivo abrogates its protein kinase activity against
p53
but has no apparent effect on the DNA binding properties of ATM. These data suggest that the cleavage of ATM during apoptosis generates a kinase-inactive protein that acts, through its DNA binding ability, in a trans-dominant-negative fashion to prevent DNA repair and DNA damage signalling.
...
PMID:Cleavage and inactivation of ATM during apoptosis. 1045 55
Rhabdomyosarcomas are a heterogeneous group of malignant tumors and are the most common soft-tissue sarcoma of childhood. Rhabdomyosarcomas resemble developing skeletal muscle, notably in their expression of the MRF family of transcription factors and the PAX3 and PAX7 genes. These PAX genes are also involved through specific translocations, t(2;13)(q35;q14) and variant t(1;13)(p36;q14) in the alveolar subtype, which result in PAX3-FKHR and PAX7-FKHR fusion genes, respectively. The fusion genes are thought critically to affect downstream targets of PAX3 and PAX7 or possibly have novel targets. Similar downstream changes may also be involved in embryonal and fusion gene negative cases. Genomic amplification of such genes as MYCN, MDM2, CDK4, and PAX7-FKHR is a feature mainly of the alveolar subtype, while specific chromosomal gains, including chromosomes 2, 8, 12, and 13, are associated with the embryonal subtype. Loss of alleles and imprinting at 11p15.5 and disruption of genes such as IGF2,
ATR
, PTC, P16, and
TP53
have also been implicated in rhabdomyosarcoma development. Whereas there is now a realistic possibility of cure in the majority of cases, there remains a subset that is resistant to multimodality therapy, including high-dose chemotherapy. Characterization of the defining molecular features of tumors that are likely to behave aggressively represents a particular challenge. Current research is leading toward a better understanding of rhabdomyosarcoma tumorigenesis, which may ultimately result in novel therapeutic strategies that increase the overall cure. Genes Chromosomes Cancer 26:275-285, 1999.
...
PMID:Genes, chromosomes, and rhabdomyosarcoma. 1053 62
Stabilization of
p53
in response to DNA damage is caused by its dissociation from Mdm2, a protein that targets
p53
for degradation in the proteasome. Dissociation of
p53
from Mdm2 could be caused by DNA damage-induced
p53
posttranslational modifications. The ATM and
ATR
kinases, whose activation in response to ionizing radiation (IR) and UV light, respectively, is required for
p53
stabilization, directly phosphorylate
p53
on Ser-15. However, phosphorylation of Ser-15 is critical for the apoptotic activity of
p53
and not for
p53
stabilization. Thus, whether any
p53
modifications, and which, underlie disruption of the
p53
-Mdm2 complex after DNA damage remains to be determined. We analyzed the IR- and UV light-induced stabilization of
p53
proteins with substitutions of Ser known to be posttranslationally modified after DNA damage. Substitution of Ser-20 was sufficient to abrogate
p53
stabilization in response to both IR and UV light. Furthermore, both IR and UV light induced phosphorylation of
p53
on Ser-20, which involved the majority of nuclear
p53 protein
and weakened the interaction of
p53
with Mdm2 in vitro. ATM and
ATR
cannot phosphorylate
p53
on Ser-20. We therefore propose that ATM and
ATR
activate an, as yet unidentified, kinase that stabilizes
p53
by phosphorylating it on Ser-20.
...
PMID:Phosphorylation of Ser-20 mediates stabilization of human p53 in response to DNA damage. 1057 Jan 49
ATR
is a large, > 300 kDa protein containing a carboxy-terminus kinase domain related to PI-3 kinase, and is homologous to the ATM gene product in human cells and the rad3/MEC1 proteins in yeast. These proteins, together with the DNA-PK, are part of a new family of PI-3 kinase related proteins. All members of this family play important roles in checkpoints which operate to permit cell survival following many forms of DNA damage. We have expressed
ATR
protein in HEK293 cells and purified the protein to near-homogeneity. We show that pure
ATR
is a protein kinase which is activated by circular single-stranded, double-stranded or linear DNA. Thus
ATR
is a new member of a sub-family of PIK related kinases, founded by the DNA-PK, which are activated in the presence of DNA. Unlike DNA-PK,
ATR
does not appear to require Ku proteins for its activation by DNA. We show directly that, like ATM and DNA-PK,
ATR
phosphorylates the genome surveillance
protein p53
on serine 15, a site which is up-regulated in response to DNA damage. In addition, we find that
ATR
has a substrate specificity similar to, but unique from, the DNA-PK in vitro, suggesting that these proteins have overlapping but distinct functions in vivo. Finally, we find that the kinase activity of
ATR
in the presence and absence of DNA is suppressed by caffeine, a compound which is known to induce loss of checkpoint control. Our results are consistent with the notion that
ATR
plays a role in monitoring DNA structure and phosphorylation of proteins involved in the DNA damage response pathways.
...
PMID:ATR is a caffeine-sensitive, DNA-activated protein kinase with a substrate specificity distinct from DNA-PK. 1059 77
Ataxia telangiectasia mutated (ATM) phosphorylates
p53 protein
in response to ionizing radiation, but the complex phenotype of AT cells suggests that it must have other cellular substrates as well. To identify substrates for ATM and the related kinases
ATR
and DNA-PK, we optimized in vitro kinase assays and developed a rapid peptide screening method to determine general phosphorylation consensus sequences. ATM and
ATR
require Mn(2+), but not DNA ends or Ku proteins, for optimal in vitro activity while DNA-PKCs requires Mg(2+), DNA ends, and Ku proteins. From
p53
peptide mutagenesis analysis, we found that the sequence S/TQ is a minimal essential requirement for all three kinases. In addition, hydrophobic amino acids and negatively charged amino acids immediately NH(2)-terminal to serine or threonine are positive determinants and positively charged amino acids in the region are negative determinants for substrate phosphorylation. We determined a general phosphorylation consensus sequence for ATM and identified putative in vitro targets by using glutathione S-transferase peptides as substrates. Putative ATM in vitro targets include p95/nibrin, Mre11, Brca1, Rad17, PTS, WRN, and ATM (S440) itself. Brca2, phosphatidylinositol 3-kinase, and DNA-5B peptides were phosphorylated specifically by
ATR
, and DNA Ligase IV is a specific in vitro substrate of DNA-PK.
...
PMID:Substrate specificities and identification of putative substrates of ATM kinase family members. 1060 6
1
2
3
4
5
6
7
8
9
10
Next >>